Effects of Robotic Rehabilitation in Post-Stroke Patients
NCT ID: NCT04494685
Last Updated: 2020-07-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
40 participants
INTERVENTIONAL
2020-08-01
2021-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Robotic rehabilitation
Robotic rehabilitation with Erigo® equipment (Hocoma, Volketswil, Switzerland).
Intervention group (Robotic rehabilitation)
Robotic rehabilitation with Erigo® equipment (Hocoma, Volketswil, Switzerland). The training protocol has a progression of the board inclination up to 90º associated with flexion/extension movements of the knees and hips, with time evolution of up to 40 minutes. Such equipment is associated with electrostimulation of the quadriceps, hamstrings, sural triceps and anterior tibialis.
Conventional physiotherapy
The protocol will be based on lower limb exercises, aiming at maintaining and gaining muscle strength through passive, assisted or active mobilization, when possible, on the affected side.
Control group (Conventional physiotherapy)
Knee and hip flexion and extension movements, hip adduction, and abduction, respecting the articular physiology of each joint. Weight transfer will also be performed in the sitting and standing position, mini squat, and gait training. All exercises will have a total of 10 repetitions in three sets. In the end, stretching of the upper and lower limbs will be performed.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Intervention group (Robotic rehabilitation)
Robotic rehabilitation with Erigo® equipment (Hocoma, Volketswil, Switzerland). The training protocol has a progression of the board inclination up to 90º associated with flexion/extension movements of the knees and hips, with time evolution of up to 40 minutes. Such equipment is associated with electrostimulation of the quadriceps, hamstrings, sural triceps and anterior tibialis.
Control group (Conventional physiotherapy)
Knee and hip flexion and extension movements, hip adduction, and abduction, respecting the articular physiology of each joint. Weight transfer will also be performed in the sitting and standing position, mini squat, and gait training. All exercises will have a total of 10 repetitions in three sets. In the end, stretching of the upper and lower limbs will be performed.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* To present hemiparesis or muscle weakness defined by the Medical Research Council (MRC) score;
* To understand simple commands and being able to report signs of discomfort.
Exclusion Criteria
* Recent acute myocardial infarction (24 hours) and/or uncontrolled arrhythmias;
* Intracranial hypertension (PIC\> 20mmHg);
* Uncontrolled hypertension (PAS\> 230 mmHg and PAD\> 120 mmHg) or PAM \<60 mmHg;
* Decompensated heart failure;
* To present important hemodynamic changes during training;
* Peripheral vascular disease in the lower limb such as untreated deep vein thrombosis;
* Unconsolidated fractures or severe joint pain;
* Feverish state;
* Smokers;
* Epidermal lesions on the thighs that make it impossible to place self-adhesive electrodes for electrical stimulation;
* Pre-existing neuromuscular disease;
* Signs of rhabdomyolysis;
* Pregnancy.
18 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Federal University of Health Science of Porto Alegre
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Rodrigo Della Méa Plentz
PhD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Rodrigo DM Plentz, PhD
Role: PRINCIPAL_INVESTIGATOR
Federal University of Health Sciences of Porto Alegre
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Stroke_ERIGO
Identifier Type: -
Identifier Source: org_study_id